Jiangsu Cowin Biotech Co., Ltd.SSE: 688426

2024 Annual Report

Apr 25, 2025 · Issued by Jiangsu Cowin Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 25, 2025

On 6ix: 6ix.com/news/2024-annual-report-165

2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Jiangsu Cowin Biotech Co., Ltd. on 6ix

Earlier from Jiangsu Cowin Biotech

Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Human Septin9, SDC2, and NDRG4 Gene Methylation Detection KitMar 8, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 28, 2025
Announcement on Implementation Results of Share Repurchase and Share ChangesFeb 8, 2025
Announcement on Progress in Repurchasing Shares through Call AuctionFeb 6, 2025
Announcement on Expected Loss in Annual Performance for 2024Jan 16, 2025

Later from Jiangsu Cowin Biotech

All Jiangsu Cowin Biotech news releases

Follow Jiangsu Cowin Biotech into a list and get an email when it puts out news.

Follow Jiangsu Cowin Biotech